Eve Barys/LinkedIn
May 7, 2026, 15:34
Eve Barys: What’s New – Thrombosis in Immune Thrombocytopenia
Eve Barys, Sr. Strategic Account Executive at Wolters Kluwer Health, shared a post on LinkedIn:
“Immune thrombocytopenia (ITP) is generally associated with bleeding, but individuals with ITP can also develop thrombosis.
A study of ITP documented venous thrombosis in about 4 percent of patients.
Features associated with thrombosis included older age, prior thrombosis, secondary ITP, and use of a thrombopoietin receptor agonist.
Management with anticoagulation is appropriate, and some individuals may require more intensive ITP therapies to raise the platelet count and allow for full anticoagulation.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?